Copyright
©The Author(s) 2021.
World J Psychiatr. Apr 19, 2021; 11(4): 124-132
Published online Apr 19, 2021. doi: 10.5498/wjp.v11.i4.124
Published online Apr 19, 2021. doi: 10.5498/wjp.v11.i4.124
Parameters | n (%) |
Age in yr, mean ± SD | 44.1 ± 11.6 |
Sex, M:F | 9:5 (1.8:1) |
Duration of illness in wk | 13.5 ± 5.8 |
Clinical characteristics | |
Tremor | 14 (100) |
Hyperreflexia | 14 (100) |
Clonus | 13 (93) |
Spasticity-rigidity | 11 (79) |
Tachycardia | 9 (64) |
Generalized pain | 7 (50) |
Insomnia | 7 (50) |
Irritability-restlessness | 7 (50) |
Stiffness | 6 (43) |
Diaphoresis | 6 (43) |
Gait disturbances | 5 (36) |
Bowel disturbances | 5 (36) |
Dizziness | 4 (29) |
Sexual dysfunctions | 3 (21) |
Nystagmus | 3 (21) |
Hypertension | 2 (14) |
Incoordination | 2 (14) |
Fatigue | 2 (14) |
Fulfilments of SS criteria | |
Hunter criteria | 14 (100) |
Sternbach’s criteria | 11 (78) |
Serotonergic agents implicated in 14 cases | |
Amitriptyline | 6 (43) |
Tramadol | 5 (36) |
Valproate | 5 (36) |
Paroxetine | 2 (14) |
Sertraline | 2 (14) |
Citalopram | 1 (7) |
Fluoxetine | 1 (7) |
- Citation: Prakash S, Rathore C, Rana K, Roychowdhury D, Lodha D. Chronic serotonin syndrome: A retrospective study. World J Psychiatr 2021; 11(4): 124-132
- URL: https://www.wjgnet.com/2220-3206/full/v11/i4/124.htm
- DOI: https://dx.doi.org/10.5498/wjp.v11.i4.124